Clinical evaluation of the ResistancePlus MG FleXible test on the GeneXpert Infinity-48s instrument: a near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance.

[1]  T. Pumarola,et al.  Mycoplasma genitalium and antimicrobial resistance in Europe: a comprehensive review , 2020, International journal of STD & AIDS.

[2]  J. Jensen,et al.  Evaluation of the ResistancePlus MG FleXible Assay for Detection of Wild-Type and 23S rRNA-Mutated Mycoplasma genitalium Strains , 2020, Journal of Clinical Microbiology.

[3]  D. Whiley,et al.  Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations , 2020, Journal of Clinical Microbiology.

[4]  Holm,et al.  Evaluation of the ResistancePlus® MG FleXible assay for the detection of wild-type and 23S rRNA-mutated Mycoplasma genitalium , 2020 .

[5]  L. Vodstrcil,et al.  Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  T. Pumarola,et al.  Mycoplasma genitalium macrolide resistance update: Rate among a 2016-2017 cohort of patients in Barcelona, Spain. , 2020, Enfermedades infecciosas y microbiologia clinica.

[7]  X. Beristain,et al.  Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017 , 2019, Emerging infectious diseases.

[8]  Federico García,et al.  Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections , 2019, PloS one.

[9]  F. Hagen,et al.  Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017 , 2019, Emerging infectious diseases.

[10]  S. Garland,et al.  Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  S. Kutsuna,et al.  Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains , 2018, PloS one.

[12]  N. Woodford,et al.  Evaluation of the Mycoplasma genitalium Resistance Plus kit for the detection of M. genitalium and mutations associated with macrolide resistance , 2017, Sexually Transmitted Infections.

[13]  J. Jensen,et al.  Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013–2014 Cohort of Patients in Barcelona, Spain , 2017, Sexually transmitted diseases.

[14]  S. Garland,et al.  Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium , 2017, Emerging infectious diseases.

[15]  S. Garland,et al.  Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide Resistance , 2017, Journal of Clinical Microbiology.

[16]  M. Unemo,et al.  Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium , 2017, Nature Reviews Urology.

[17]  S. Pereyre,et al.  Evaluation of a Commercial Multiplex Quantitative PCR (qPCR) Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance-Associated Mutations in Clinical Specimens , 2016, Journal of Clinical Microbiology.

[18]  M. Cusini,et al.  2016 European guideline on Mycoplasma genitalium infections , 2016, Journal of the European Academy of Dermatology and Venereology.

[19]  C. Burnham,et al.  The ABCs of STIs: An Update on Sexually Transmitted Infections. , 2016, Clinical chemistry.

[20]  J. Hocking,et al.  The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  G. Gilbert,et al.  Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance , 2013, International journal of STD & AIDS.

[22]  Navneet R. Hakhu,et al.  Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Jensen.  Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene. , 2012, Methods in molecular biology.

[24]  D. Taylor-Robinson,et al.  Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly , 2011, Clinical Microbiology Reviews.

[25]  S. Tabrizi,et al.  Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  S. Garland,et al.  Azithromycin Failure in Mycoplasma genitalium Urethritis , 2006, Emerging infectious diseases.